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Compliance mismatch is a significant challenge to long-term patency in small-diameter bypass grafts
because it causes intimal hyperplasia and ultimately graft occlusion. Current engineered grafts are
typically stiff with high burst pressure but low compliance and low elastin expression. We postulated
that engineering small arteries on elastomeric scaffolds under dynamic mechanical stimulation would
result in strong and compliant arterial constructs. This study compares properties of engineered arterial
constructs based on biodegradable polyester scaffolds composed of either rigid poly(lactide-co-glycolide)
(PLGA) or elastomeric poly(glycerol sebacate) (PGS). Adult baboon arterial smooth muscle cells (SMCs)
were cultured in vitro for 10 days in tubular, porous scaffolds. Scaffolds were significantly stronger after
culture regardless of material, but the elastic modulus of PLGA constructs was an order of magnitude
greater than that of porcine carotid arteries and PGS constructs. Deformation was elastic in PGS
constructs and carotid arteries but plastic in PLGA constructs. Compliance of arteries and PGS constructs
were equivalent at pressures tested. Altering scaffold material from PLGA to PGS significantly decreased
collagen content and significantly increased insoluble elastin content in constructs without affecting
soluble elastin concentration in the culture medium. PLGA constructs contained no appreciable insoluble
elastin. This research demonstrates that: (1) substrate stiffness directly affects in vitro tissue develop-
ment and mechanical properties; (2) rigid materials likely inhibit elastin incorporation into the extra-
cellular matrix of engineered arterial tissues; and (3) grafts with physiologic compliance and significant
elastin content can be engineered in vitro after only days of cell culture.
 2009 Elsevier Ltd. All rights reserved.1. Introduction
Coronary heart disease is the leading cause of death in the U.S.,
with an estimated annual cost exceeding $150 billion [1]. Approx-
imately half-a-million coronary artery bypass graft procedures and
an even greater number of percutaneous arterial procedures
(coronary angioplasty, stent revascularization, endarterectomy,
etc.) are performed annually. Coronary artery bypass is associated
with better outcomes compared to percutaneous procedures [2].
The internal thoracic artery is the benchmark for coronary bypass,
but its use is limited by issues of accessibility and length [3].
Saphenous vein grafts are easiest to access and have the leasteering, McGowan Institute,
urgh, PA 15219, USA. Tel.: þ1
o), yaw20@pitt.edu (Y.Wang).
ates, 5401 McConnell Avenue,
ax: þ1 310 754 2799.
All rights reserved.impact on tissuemorbidity and patient health. However, saphenous
vein grafts used for coronary bypass occlude at much higher rates
(w50% within 10 years) compared to arterial grafts [4], under-
scoring the need to match the biological and mechanical properties
of the specific artery being replaced. Compliance mismatch influ-
ences a variety of flow and wall shear stress parameters, which in
turn regulate complex biological responses to determine vascular
remodeling outcomes such as restenosis, intimal hyperplasia, and
occlusion [5].
Compliance mismatch results in intimal hyperplasia at the
downstream anastamosis [6]. It has been suggested that increased
shear stress as a result of compliance mismatch is the root cause of
graft-associated intimal hyperplasia [7,8]. The importance of
compliance matching was first established by Abbott et al. using
a canine model to investigate compliance [9]. Canine carotid artery
autografts and femoral arteries were either compliance-matched
(1:1) ormismatched (2:5), resulting in patencies of 85% or 37% at 90
days post-implantation, respectively. Interestingly, Sonoda et al.
achieved a patency rate similar to that of Abbot et al. (86%, also in
canine common carotid) at 365 days post-implantation using
Fig. 1. Electron micrographs of scaffold luminal microstructure and cellular luminal confluence. Luminal surfaces appeared similar in micrographs of (A) PGS and (B) PLGA scaffolds
(scale bars¼ 100 mm). Luminal microstructure also appeared similar in high-magnification micrographs of (C) PGS and (D) PLGA scaffolds (scale bars¼ 10 mm). Cellular confluence
appeared equivalent on the luminal surfaces of (E) PGS and (F) PLGA arterial constructs cultured with adult baboon arterial SMCs for 10 days. Topography varied due to scaffold
compaction and individual SMCs were visible on their luminal surfaces in some locations. Dark spots (E) are charging artifacts.
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physiologic compliance [10].
In contrast to these studies, abluminal constraint of canine
common iliac artery sections suggested that compliance mismatch
alone does not cause intimal hyperplasia [11]. Flow irregularities at
the downstream anastomosis influence protein transport [12] and
are likely to contribute to intimal hyperplasia by increasing resi-
dence time of chemotactic factors [13] and the concentration of
growth factors associated with intimal hyperplasia and athero-
sclerosis as well as mitogenic factors associated with higher cell
proliferation [14]. Additionally, compliance mismatch increases
suture line stresses at anastomoses. Considered collectively, these
results indicate the importance of compliance matching for
vascular graft patency.
An extracorporeal source of small-diameter (<5 mm) non-
thrombogenic vascular grafts possessing physiologic compliance
would prevent the harvesting of multiple native vessels whenunfavorable remodeling occurs and would provide an alternative
when autologous grafts are unavailable. However, current engi-
neered grafts are challenged by compliance mismatch and throm-
bosis, resulting in undesirable tissue remodeling and graft
occlusion.
Artificial grafts have been engineered with super-physiologic
burst pressures [15–20] and in vivo patency rates ofw80% at time
points beyond three months [15,17,18,21], indicating that aneurysm
and thrombosis, challenges which cause graft failure in the short-
term, are being overcome. However, research efforts have not yet
produced an engineered graft with physiologic compliance. Elas-
tomer-based grafts may facilitate compliance matching, thereby
improving long-term patency rates for engineered vasculature. We
have previously developed [22] and improved [23] a method to
fabricate tubular, porous scaffolds from a biodegradable elastomer,
poly(glycerol sebacate) (PGS), and shown that adult baboon arterial
smooth muscle cells (SMCs) cultured on PGS proliferate and
Fig. 2. Macroscopic and histological appearance of arteries and engineered arterial constructs. Macroscopic appearance of (A) the tunicae media and intima of a porcine carotid
artery, a PGS construct, and a PLGA construct (shown left to right). Staining with H&E to qualitatively assess cell and protein distribution showed that (B) porcine carotid arteries
were dense and highly organized while (C) PGS constructs and (D) PLGA constructs had concentrations of cells and proteins at the luminal and abluminal surfaces and cells
distributed throughout the scaffold walls. Ruler divisions¼ 1.0 mm and scale bars¼ 250 mm, L ¼ lumen. For images of complete histological cross-sections see Fig. S6.
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the ability of PGS scaffolds to support co-expression of elastin and
collagen by adult SMCs in three-dimensional in vitro culture,
resulting in highly distensible engineered tissues [25].
We hypothesized that grafts engineered from compliant
materials and adult vascular SMCs under biomimetic in vitro
culture conditions could develop compliance comparable to
autologous arteries. To test our hypothesis, constructs were
created from tubular, porous scaffolds composed of PGS or the
benchmark biomaterial poly(lactide-co-glycolide) (PLGA), each
cultured with SMCs under identical conditions. PLGA was chosen
based on its similarities to PGS: both are biodegradable polyesters
with no known bioactivity, and both generate carboxylic acid and
alcohol upon hydrolysis. Although PLGA and PGS differ in
hydrophilicity, and therefore initial surface protein adsorption
from culture medium is likely different, this difference is expected
to be attenuated during culture by cell-dominated protein
deposition on scaffold surfaces. The critical difference between
PLGA and PGS is therefore elasticity; PLGA is a rigid material,
whereas PGS is a compliant elastomer with mechanical properties
that more closely match the properties of cardiovascular tissues
[26–28].
2. Materials and methods
2.1. Overall approach to scaffold fabrication
Scaffolds were fabricated from PGS [26] synthesized in-house [22] or from PLGA
(5050 DLG 5E; Lakeshore Biomaterials, Birmingham, AL, USA) using a solvent casting
and particulate leaching process [23,29]. Sodium chloride (EMD Chemicals, Gibbs-
town, NJ, USA) was ground and sieved to select salt particles with a size range of75–90 mm as porogens. Two new methods of PGS scaffold fabrication were devel-
oped to reduce scaffold geometric and mechanical tolerances and decrease scaffold
wall thickness. The newmethods were compared to a high-yield method previously
developed [23]. PGS and PLGA scaffolds selected for cell culture were fabricated
using only the most advantageous method.2.2. Methods of scaffold fabrication
The previous scaffold fabrication method [23] (denoted as type A scaffolds) used
in-house bifurcated poly(tetrafluoroethylene) (PTFE) molds with a cylindrical recess
(ID 7.94 mm, length 60 mm). Salt particles were added between the larger recess
and a heat-shrinkable mandrel (OD 5.28 mm, ID 4.76 mm). Lecithin mold release
(Diversified Brands, Cleveland, OH, USA) was applied to all salt-contacting mold
surfaces prior to assembly and salt loading through a slot in the center of one half.
Salt was fused at 88% humidity and 37 C for 6.5 h.
The second scaffold fabrication method (denoted as type B scaffolds) replaced
the bifurcated outer mold with a 90-mm length of PTFE tubing (OD 12.7 mm, ID
7.94 mm; McMaster-Carr, Aurora, OH, USA) coated with lecithin mold release.
Spacing and concentricity between the outer PTFE tubing and the mandrel was
maintained by a ring of PTFE tubing (OD 7.94 mm, ID 4.76 mm, 1.0 mm length;
McMaster-Carr) with four non-contiguous sections of its outer diameter cut away for
ventilation. Salt was loaded into the vertical mold assembly with the spacer ring at
its bottom while the upper end of the mandrel was manually centered. Salt was
fused at 88% humidity and 37 C for 6.5 h.
The third scaffold fabrication method (denoted as type C scaffolds) replaced the
outer PTFE tubing with a 70-mm length of glass tubing (OD 9.0 mm, wall thickness
1.0 mm; Small Parts, Miramar, FL, USA) coated on the inner surface with 1.0% hya-
luronic acid (HA; Sigma–Aldrich, St. Louis, MO, USA), which was dried overnight at
37 C and 100 mTorr. The heat-shrinkable mandrel, spacer ring, and salt loading
were the same as in the secondmethod. Salt was fused at 88% humidity and 37 C for
20 min. A briefer fusion period was likely required because the hyaluronic acid
accelerated moisture sequestration.
Salt templates were dried overnight at 37 C and 100 mTorr regardless of
method. Heat-shrinkablemandrels were removed at 120 C for 5 min. Salt templates
remained in the outer molds during polymer addition for type B or C scaffolds. PGS
Fig. 3. Deformation and elastic recovery of arteries and engineered arterial constructs in transverse compression. Segments of porcine carotid arteries, PGS or PLGA constructs, and
PGS or PLGA scaffolds were compressed perpendicular to their axis. Five force-extension cycles are shown chronologically for each tested segment. Elastic recovery was observed in
(A) arteries and (B) PGS constructs, while plastic deformation was observed in (C) PLGA constructs. Scaffolds composed of (D) PGS or (E) PLGA showed similar behavior to their
construct counterparts with or without degradation (degraded scaffold data not shown). Increases in moduli caused by ECM production were evident from steeper regions near the
end of the force-extension curves of (B) PGS constructs compared to (D) PGS scaffolds and a notable difference in the toe regions and near the end of the force-extension curves of
(B) PLGA constructs compared to (D) PLGA scaffolds (see also Fig. 4). The tunica adventitia of arteries was removed prior to testing.
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added at 4.0 mg polymer per mm salt template length. Tetrahydrofuranwas allowed
to evaporate for at least one hour. PGS was cured at 150 C and 100 mTorr for 24 h.
PLGAwas placed overnight in a vacuum oven (20 C,100 mTorr) to remove all THF. A
series of twowater baths (first bathw24 h, second bath>48 h) was used to dissolve
the salt template and release type B or C polymer tubes from their molds. Individual
scaffolds were obtained by bisecting the tubes into 30-mm sections. Scaffolds were
lyophilized and stored dry.
2.3. Scaffold evaluation
The percentage of usable scaffolds (yield) and scaffold dimensions, micro-
structure, porosity, and mechanical properties were determined as previously
described [23]. Scaffolds that were free of through-cracks and holes along their
entire length were considered usable. Scaffold wall thickness was measured at eightevenly spaced locations around the circumference of 5-mm scaffold segments.
Randomly selected scaffold cross-sections and lumens were sputter-coated with
gold and observed via scanning electron microscope. Porosity was calculated using
an ethanol displacement method previously described [30]. Porosity measurements
of two 5.0-mm type C scaffold segments by micro-computed tomography [31] fell
within one standard deviation of the mean as calculated from ethanol submersion
data, but micro-computed tomography was not used to evaluate porosity due to
prohibitive time and cost requirements.
Scaffolds were cut into 5-mm segments and tested to failure under uniaxial
tension (tension perpendicular to the segment axis) at 0.20 mm/s after soaking for
24 h in PBS [23]. Ultimate tensile stress was calculated from maximum force and
wall cross-sectional area. Strain at failure was calculated from the change in luminal
circumference normalized by initial circumference. Stress and strain at intermediate
points were calculated to determine each segment’s linear elastic modulus in the
linear stress–strain region of 40–80% of the ultimate tensile stress.
Fig. 4. Elastic moduli of arteries and engineered arterial constructs. Segments of porcine carotid arteries, PGS or PLGA constructs, and PGS or PLGA scaffolds with or without
degradation were compressed perpendicular to their axis. Transverse compressive elastic moduli (Ec) were determined from the second, third, and fourth force-extension cycles to
50% strain. (A) Comparison of all experimental groups and controls (n¼ 12, 12, 12, 8, 10, 12, and 12 from left to right). *Ec of PLGA constructs was significantly higher than all other
groups. **Ec of undegraded and degraded PLGA scaffolds were significantly higher than Ec of porcine carotid arteries and all PGS groups. (B) Comparison of positive control and PGS
groups only. *Ec of arteries was significantly higher than all PGS groups. **Ec of PGS constructs was significantly higher than Ec of undegraded and degraded PGS scaffolds.
#The
tunica adventitia of arteries was removed prior to testing.
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into 5-mm segments, placed in pre-weighed microcentrifuge tubes, sterilized by
steam autoclaving for PGS (15 min at 150 C) or ethylene oxide gas for PLGA (>72 h
of subsequent outgassing), and weighed. Complete culture medium was added
(2.00 ml per tube) followed by horizontal rotation at 2.0 rpm and 37 C for 10 days.
The ratios of surface area to volume for degraded scaffold segments and scaffolds in
culture were identical (80 mm2 per ml). After transverse compression testing (see
Section 2.7), scaffold segments were returned to their tubes, frozen, lyophilized, and
re-weighed. Pre-weighed microcentrifuge tubes containing only 2.00 ml complete
culture medium were likewise frozen, lyophilized, and re-weighed as a control.
Note: Based on scaffold evaluation results, only type C scaffolds were used for
cell culture to create engineered arterial constructs.Fig. 5. Elastic recovery of arteries and engineered arterial constructs. Segments of
porcine carotid arteries and whole PGS constructs were pressure–diameter tested for
comparison. Constructs were cycled to each target pressure three times, with hyster-
esis observed only during the first cycle. Complete elastic recovery was observed after
the initial cycle to each target pressure in (A) porcine carotid arteries up to and
including the highest pressure tested (240 mmHg) and in (B) PGS constructs up to
pressures near their burst pressure (cycles to 50 mmHg are shown for a construct with
a burst pressure of 56 mmHg). The tunica adventitia of porcine carotid arteries was
removed prior to testing.2.4. Cell culture
A pulsatile perfusion bioreactor was designed for culturing vascular cells on
tubular porous scaffolds in vitro as previously described [23,25]. The bioreactor
included four medium reservoirs, eight flow circuits (two per reservoir) comprised
of silicone tubing with coiled sections for gas exchange, scaffold-containing cham-
bers with shorter silicone tubing assemblies that could be detached from the bulk of
each circuit, and additional silicone tubing to return medium to the reservoirs. Flow
was driven and controlled by a Masterflex L/S pump (model 77301-22; Cole–Parmer
Instrument Company, Vernon Hills, IL).
Smooth muscle cells (SMCs) were isolated from the carotid arteries of juvenile
male baboons (Papio anubis) and characterized in two-dimensional culture prior to
passaging and seeding [24]. Complete culture medium contained MCDB 131 with
10% irradiated FBS, 1.0% L-glutamine, and 50 mcg/ml ascorbic acid, with 100 IU/ml
penicillin, 100 mcg/ml streptomycin, and 0.25 mcg/ml amphotericin B as antibiotics
and antimycotic.
PGS scaffolds were aligned with the luminal tubing of their chambers using 1.0-
mm bands of heat-shrinkable food-grade acrylated poly(olefin) (OD 6.88 mm, ID
6.35 mm; McMaster-Carr) shrunk around each end of the scaffold by heating at
120 C. PLGA scaffolds were aligned with the luminal tubing of their chambers using
1.0-mmbands of silicone tubing (OD 6.35 mm, ID 3.18 mm;McMaster-Carr) abutting
each end of the scaffold.
In preparation for cell seeding, scaffolds attached to their chambers were ster-
ilized (same method as was used for the degradation study: steam for PGS or
ethylene oxide gas for PLGA) and pretreated with a series of perfusions at 1.0 ml/min
to remove any unreacted monomers and oligomers and residual salt prior to cell
seeding: 70% ethanol for 1 h, 50% ethanol for 1 h, 25% ethanol for 1 h, and PBS for 2 h.
During 30 min of perfusion with each pretreatment fluid, flow was forced through
the scaffold wall by clamping the luminal tubing outlet. Scaffolds were then
conditioned with complete culture medium for 24 h.
Each scaffold within its chamber was detached from its flow circuit, and SMCs
(passage 5) were seeded in the scaffold lumen (2.0106 SMCs per cm2 of luminal
surface area) followed by four hours of horizontal rotation. Reservoirs received fresh
medium (250 ml per reservoir), scaffold chambers were reattached to their flow
circuits, and through-wall perfusionwas resumed at 1.0 ml/min for 15 min followed
by luminal flow. The flow rate was increased steadily from 1.0 ml/min (1.1 dynes/
cm2) on day one to 10 ml/min (11 dynes/cm2) on day 10, the termination point of the
study. Mediumwas changed on day seven, and additional ascorbic acid (50 mcg/ml)
was injected into each medium reservoir on days three and five.2.5. Positive control
The left and right common carotid arteries of Large White/Yorkshire pigs
(w30 kg, Sus scrofa domestica) were excised immediately following anesthesia
(intravenous ketamine and xylazine) and euthanasia (intravenous pentobarbital) in
accordance with the Georgia Institute of Technology’s Institutional Animal Care and
Use Committee guidelines and with their approval. Each artery was rinsed in HBSS
and the tunica adventitiawas removed using scissors and a scalpel, leaving the tunica
media and tunica intima intact. Porcine arteries were selected as controls because of
the limited availability of baboon arteries.
Fig. 6. Physiologic compliance of arteries and engineered arterial constructs. The compliance of porcine carotid arteries (gray, n¼ 4) and PGS constructs (black, n¼ 4) was
remarkably similar at the pressures tested. There was no statistical difference between the two groups. PGS scaffolds hold no pressure due to their high porosity. #The tunica
adventitia of porcine carotid arteries was removed prior to testing.
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A short segment of each artery and cultured PGS or PLGA scaffold (designated
respectivelyasPGSorPLGAconstructs)didnotundergomechanical orbiological testing
and was instead snap-frozen, cryosectioned, and stained with hematoxylin and eosin.
2.7. Mechanical evaluation of engineered arterial constructs
Only PGS constructs and artery segments of similar length underwent pressure–
diameter testing. The brittle nature of PLGA constructs prevented cannulation and
attachment to pressure–diameter testing apparatus. PGS constructs were tested to
burst and arteries were tested to the maximum pressure of the system (200 mmHg).
Vessels were attached to a flow circuit, submerged in and perfused with medium,
and stretched to l¼ 1.2 (120% of length prior to attachment). Luminal pressure was
cycled between zero and a target pressure, which was incrementally increased by
5 mmHg after three cycles to each target (rate of increasew60 mmHg/min and rate
of decreasew40 mmHg/min). Pressure was dynamically controlled using LabVIEW
(National Instruments, Austin, TX) and recorded at 0.25–1.0 Hz while vessel dia-
meter was observed via light microscopy, with images of the external diameter
recorded and the diameter measured synchronously with pressure. Pressure–
diameter data were used to determine elastic recovery and compliance of arteries
and constructs. Mean diameter was calculated along a portion of the vessel lengthFig. 7. Total collagen content in arteries and engineered arterial constructs. Total collagen c
were measured per unit wet weight by quantifying 4-hydroxyproline content. (A) Compariso
carotid arteries contained significantly more collagen than all other groups. (B) Compari
significantly more collagen than PGS constructs and uncultured scaffolds. **PGS constructs co
porcine carotid arteries was removed prior to testing.from image data. Compliance was defined as the inverse of Peterson’s elastic
modulus according to the following equation: C¼ (DD/D0)/DP [32].
Scaffold, construct, and artery segments (length w5 mm) were tested to 50%
strain in transverse compression (planar compression perpendicular to the segment
axis) at 0.0167 mm/s. Undegraded scaffold segments were tested after soaking for
24 h in PBS. Segments were pre-cycled to 5.0% strain approximately five times until
load stabilized atw0.05 N (range 0.02–0.10 N). Five compression cycles to 50% strain
(3Fmax) were completed in rapid succession followed by image-based measurements
of post-compression segment cross-sectional area (AC). Only artery segments
recovered to their original cylindrical geometry after testing, and AC for artery
segments was therefore multiplied by a correction factor of p/2. Elastic recovery was
determined by comparing force-extension curves and the maximum compressive
force (Fmax) for each segment’s five-cycle compression series. The strain at half-
maximum force (30.5Fmax) and Fmax were taken directly from the raw data. The
compressive modulus of elasticity (Ec) for the segment was taken as the mean of Ec
for cycles 2–4, which were calculated according to the following equation:
Ec¼ (0.50Fmax/AC)/(3Fmax 30.5Fmax).
2.8. Biological evaluation of engineered arterial constructs
Collagen content was evaluated by measuring hydroxyproline content similar to
previously reportedmethods using chloramine T [33,34]. A hydroxyproline standardontents in porcine carotid arteries, PGS or PLGA constructs, and PGS or PLGA scaffolds
n of experimental groups and controls (n¼ 4, 4, 4, 8, and 8 from left to right). *Porcine
son of experimental groups and negative controls only. *PLGA constructs contained
ntained significantly more collagen than uncultured scaffolds. #The tunica adventitia of
Fig. 8. Elastin in arteries and engineered arterial constructs. Elastin production was quantified using an elastin-binding dye. (A) Soluble elastin concentrations in culture medium
collected at the termination of culture of PGS or PLGA constructs were measured after centrifugation to remove any insoluble elastin (n¼ 4, 4, 10, and 10 from left to right). *PGS and
PLGA constructs released significant amounts of soluble elastin into culture medium. (B) Insoluble elastin contents in porcine carotid arteries, PGS or PLGA constructs, and PGS or
PLGA scaffolds were measured per unit wet weight after acid hydrolysis of each construct, which destroyed all proteins except elastin, and centrifugation to pellet insolubles (n¼ 4,
4, 4, 9, and 9 from left to right). *Arteries contained significantly more insoluble elastin than all other groups. ** PGS constructs contained significantly more insoluble elastin than
PLGA constructs and uncultured scaffolds, but PLGA constructs did not contain significantly more insoluble elastin compared to uncultured scaffolds (even if the positive control was
excluded). #The tunica adventitia of porcine carotid arteries was removed prior to testing.
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construct segments (length w5 mm) were cut into pieces no larger than 1.0 mm2
prior to colorimetric collagen quantification. Total collagen per wet mass of each
sample was calculated from the hydroxyproline standard curve. Paired measure-
ments of standards and experimental samples taken in triplicate varied less than 5%.
Medium was collected from each chamber at the termination of culture and
evaluated for soluble elastin content using a Fastin Elastin Assay kit [35–37] (kit
F2000; Biocolor Ltd., Carrickfergus, UK) following kit instructions after centrifuga-
tion to remove tissue fragments, cells, and other insolubles. Samples of unused
culture medium incubated with uncultured scaffolds for 10 days were evaluated as
a negative control. Elastin concentration in culture medium from the scaffold
chambers was calculated from the a-elastin standard curve.
Tissue samples were evaluated for insoluble elastin content using a Fastin
Elastin Assay kit (kit F2000) after acid hydrolysis of the tissue to destroy all other
proteins, including soluble elastin. Construct and scaffold segments (lengthw5 mm)
were cut into pieces no larger than 1.0 mm2 and digestedwith oxalic acid and heat at
least three times. Elastin concentration in the supernatant was measured using the
kit instructions, and total elastin per wetmass of the samplewas calculated from the
elastin standard curve. For all elastin assays, standard duplicates had means within
5% of one another and sample duplicates varied less than 10% as allowed by kit
instructions.
2.9. Statistical analysis
Results are expressed as mean standard deviation. Statistical significance
(p< 0.05) was determined by one-way analysis of variance and a Tukey–Kramer
post-hoc test.
3. Results
3.1. Process yields, scaffold properties, and cellular confluence
Scaffolds fabricated using a heat-shrinkable mandrel and hya-
luronic acid-coated glass tubing (type C scaffolds) were comparable
to earlier scaffolds in their yield (Fig. S1) and porosity (Fig. S2) and
demonstrated advantages in geometry (Fig. S3), mechanical prop-
erties (Fig. S4), and culture time required for SMC confluence
(Fig. S5). The yields for PGS and PLGA type C scaffolds were not
significantly different (97% 13% and 93% 18% of the scaffolds
were usable respectively). Scaffold wall thickness did not vary
significantly between PGS and PLGA scaffolds, which were
28218 mm and 29017 mm respectively. Porosities were not
significantly different and were 84.6 0.6% for PGS scaffolds
compared to 84.2 0.9% for PLGA scaffolds. Luminal surfaces of PGS
and PLGA scaffolds appeared similar (Fig. 1A,B), includingmicrostructural features that would be encountered by cells during
initial adhesion and subsequent migration and proliferation
(Fig.1C,D). SMCswere similarly confluent on the luminal surfaces of
engineered arterial constructs based on PGS or PLGA (designated
respectively as PGS constructs and PLGA constructs) on day 10 of
culture (Fig. 1E,F).
3.2. Macroscopic and histological appearance
Radial and longitudinal compaction of PGS scaffolds was
noticeable by day five. Radial and longitudinal compaction of PLGA
scaffolds was noticeable by day three and began to inhibit main-
tenance of luminal flow by day five. PGS constructs retained their
scaffolds’ cylindrical geometry (Fig. 2A, Fig. S6). Porcine carotid
arteries contained dense circumferential bands of cells and extra-
cellular matrix (ECM) proteins organized within the artery wall
(Fig. 2B). PGS constructs had concentrations of cells and proteins at
the luminal and abluminal surfaces and cells scattered throughout
the scaffold walls (Fig. 2C). The distribution of cells and proteins in
PLGA constructs resembled that of PGS constructs but with greater
scaffold compaction (Fig. 2D).
3.3. Construct mechanical properties
During five compression cycles to 50% strain, segments of
porcine carotid arteries and PGS constructs showed almost no
measurable decrease in maximum force (Fmax) (Fig. 3A,B). Each
segment had nearly identical force-extension curves for all five
cycles, indicating that deformation was elastic. In contrast, PLGA
construct segments required much greater force for equivalent
deformation and strain, and Fmax decreased with each subsequent
cycle (Fig. 3C). The initial compression cycle of PLGA construct
segments showed a steady increase in force during platen exten-
sion, but subsequent cycles showed abrupt increases in force
during late stages of platen extension, a behavior indicative of
plastic deformation. Force-extension data of PGS and PLGA scaf-
folds likewise showed elastic and plastic deformation, respectively
(Fig. 3D,E).
The compressive elastic modulus (Ec) of PLGA constructs was
significantly higher compared to Ec of all other groups, including
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higher compared to Ec of porcine carotid arteries, PGS constructs,
and PGS scaffolds. When data for arteries and PGS groups were
compared independent of PLGA groups, Ec of arteries was signifi-
cantly higher than Ec of all PGS groups (Fig. 4B). The Ec of PGS
constructs was significantly higher than that of the PGS scaffolds.
Degradation did not significantly change Ec (Fig. 4) or mass (Fig. S7)
for scaffold segments of either PGS or PLGA.
Hysteresis in porcine carotid arteries (Fig. 5A) and PGS
constructs (Fig. 5B) during pressure-diameter testing was observed
only for the first cycle to each target pressure, with subsequent
cycles demonstrating complete elastic recovery. The brittle nature
of PLGA constructs prevented cannulation and adequate sealing at
cannulae-construct junctions for pressure-diameter testing.
Compliance of porcine carotid arteries and PGS constructs were
remarkably similar at pressures up to 56 mmHg, the highest burst
pressure achieved for the PGS constructs after only 10 days of
culture (Fig. 6). Artery segments excised at different distances from
the aorta provided a representative compliance range for the
porcine common carotid, with artery segments isolated at locations
closer to the aorta showing higher compliance. Mean burst pres-
sure for PGS constructs was 2719 mmHg. In contrast, uncultured
scaffolds hold no pressure due to their high porosity, and wet
scaffolds have been shown to be significantly weaker (w15% of
tensile strength) compared to scaffolds cultured with SMCs for
three weeks [25].
3.4. Construct biological properties
Collagen content of porcine carotid arteries exceeded collagen
content of PGS and PLGA constructs cultured for 10 days by more
than an order of magnitude (Fig. 7A). Comparison of experimental
groups and negative controls showed that all constructs had
significantly higher collagen content than uncultured scaffolds and
that PLGA constructs contained significantly more collagen than
PGS constructs (Fig. 7B).
Soluble elastin concentrations in culture medium collected on
day 10 were equivalent for PGS and PLGA constructs and were
significantly higher than complete culture medium incubated with
uncultured scaffolds (Fig. 8A). However, PGS constructs contained
significantly more insoluble elastin than PLGA constructs and
uncultured scaffolds, while insoluble elastin content of PLGA
constructs did not significantly vary from uncultured scaffolds
(Fig. 8B). After only 10 days of culture PGS constructs contained 35%
as much insoluble elastin as porcine carotid arteries.
4. Discussion
We have demonstrated that elastomer-based engineered arte-
rial constructs can match the compliance of native arteries (Fig. 6),
including elastic recovery (Fig. 5). The tissue of these constructs
contains more than one third of the insoluble elastin found in
native arteries (Fig. 8B). Although the burst pressure is sub-physi-
ologic, the in vitro culture time was only 10 days. Variation in burst
pressures of PGS constructs was probably a reflection of howevenly
distributed cells and ECM were longitudinally and circum-
ferentially within construct lumens, especially because tubular,
porous PGS scaffolds hold no pressure and are significantly weaker
than cultured scaffolds [25]. Since the weakest section of the
construct wall determined burst pressure, small differences in cell
distribution and seeding efficiency would amplify differences in
burst pressure. Additionally, lower seeding efficiency would result
in a larger percentage of SMCs at the fluid-cell interface in the
lumen, exposing a larger fraction of SMCs to non-physiologic shear
stress and causing them to proliferate at a lower rate during earlystages of culture [38], further amplifying differences between
constructs. Increased culture time and seeding efficiency may
increase burst pressures and decrease variation.
PLGA and PGS scaffolds were comparable in their wall thickness,
porosity, and luminal microstructure prior to cell culture (Fig. 1A–
D). Cellular confluence in the two materials was similar on day 10
(Fig. 1E,F), with differences attributable to unequal scaffold
compaction: macroscopically PGS construct lumens were smooth
and PLGA construct lumenswere increasingly rough during culture.
Equal concentrations of SMCs were observed at the lumen and
ablumen of PLGA constructs rather than higher concentrations at
the lumen as in PGS constructs (Fig. 2B–D). This wasmost likely due
to PLGA scaffold breaches caused by compaction and subsequent
through-wall SMC migration and proliferation. However, PGS and
PLGA degradation rates appeared to be similar since moduli (Fig. 4)
and masses (Fig. S7) of scaffold segments did not change signifi-
cantly during the 10-day degradation period.
Differences in PGS and PLGA scaffold compaction during culture
are most likely due to different deformation modes (elastic or
plastic; Fig. 3) and moduli (Fig. 4). As SMCs exert tensile forces on
the PLGA microstructure the scaffold is expected to plastically
deform, and the cumulative microscopic deformations caused by
SMCs over time will likely result in macroscopic scaffold compac-
tion during culture. In contrast, the PGS microstructure is expected
to deform elastically and then return to its original conformation as
SMCs form new focal adhesions and release others [39,40], thereby
allowing the scaffold to retain a macroscopic geometry similar to its
original shape during culture. In an environment of dynamicmicro-
forces collectively capable of compacting a scaffold with Ec on the
order of MPa (i.e. PLGA), the ability to elastically deform may be
important in retaining macroscopic geometry.
One important contribution of this study is the demonstration
that, when cultured in PGS scaffolds but not in equivalent PLGA
scaffolds, SMCs co-express collagen and elastin (Figs. 7 and 8B). Co-
expression of elastin and collagen is acknowledged as a significant
challenge in vascular tissue engineering [41,42], especially in the
absence of growth factors. Collagens and elastin are the primary
constituents of vascular ECM and key determinants of the
mechanical properties of vasculature [41,43,44]. Significant
increases in compressive elastic moduli after 10-day SMC culture
indicated that SMCs require a time course of only days to produce
substantial ECM (Figs. 7 and 8B) and thereby significantly alter
scaffold mechanical properties (Fig. 4).
Elastin and collagen content in PGS and PLGA constructs (Figs. 7
and 8B) may have been influenced by material differences such as
stiffness, chemical composition of degradation products released
into the medium during culture, and surface chemistry encoun-
tered at the cell-material interface. Any of these factors, alone or in
combination, could influence protein synthesis and incorporation
into the ECM as well as subsequent ECM remodeling by SMCs.
However, degradation products were aliphatic acids and alcohols
for both polyesters and were diluted by relatively large volumes of
medium in this study. Initial protein adsorption differences arising
from surface chemistry were likely attenuated by cell-mediated
protein adsorption and desorption at the surface throughout
culture [45–47]. Therefore, scaffold stiffness is most likely the
dominant factor causing differences in protein production in PGS
and PLGA constructs.
Scaffold stiffness did not alter the amount of soluble elastin
released intomedium by SMCs (Fig. 8A) but did significantly change
insoluble elastin content of engineered vascular tissue (Fig. 8B).
These results suggest that SMCs synthesized elastin in both mate-
rials but selectively controlled its incorporation into the ECM based
on mechanical cues from the environment. It has been proposed
that SMCs operate through homeostatic mechanisms to preserve
P.M. Crapo, Y. Wang / Biomaterials 31 (2010) 1626–16351634the mechanical properties of their environment, and that
mechanical perturbations caused by compliance mismatch may be
the root cause of graft-associated intimal hyperplasia [5]. Therefore,
increased incorporation of compliant ECM proteins such as elastin
and decreased incorporation of stiffer ECM proteins such as
collagen within PGS constructs are likely a result of homeostatic
mechanisms coupled with scaffold elasticity.
Pulsatile perfusion of compliant PGS scaffolds at 1.2 Hz (range:
0.5–1.7 Hz) was expected to increase synthesis of collagen, elastin,
and some glycosaminoglycans by increasing cyclic stretch of SMCs
[16,17,37,48]. One study showed that subjecting SMCs on poly-
(glycolic acid) (PGA) or collagen I to cyclic strain at 1.0 Hz increased
elastin and collagen synthesis regardless of scaffold material [37].
Other studies have demonstrated that pulsatile perfusion at
2.75 Hz of engineered arterial constructs improved SMC phenotype
and construct mechanical properties [16,17]. The perfused
constructs possessed sub-physiologic compliance despite using
a stiff material (PGA) organized in a compliant fibrous mesh fitted
over compliant silicone tubing [16]. The combined results of these
studies suggest that the most dominant scaffold property influ-
encing protein synthesis and deposition under dynamic conditions
is mechanics and not material. Therefore, differences in protein
synthesis and deposition in PGS and PLGA constructs could be
attributed mainly to differences in how PGS and PLGA transduce
mechanical stimulation rather than scaffold chemistry. Results
from previous studies also suggest that, with an appropriate
amount of collagen gel coated on synthetic-polymer scaffolds,
collagen production could be increased to create engineered arte-
rial constructs with a more balanced ECM profile [49].5. Conclusion
This work was motivated by the prevalence of coronary heart
disease and the fact that graft compliance mismatch reduces long-
term patency. When cultured three-dimensionally in tubular,
porous PGS scaffolds under cyclic strain for 10 days, adult vascular
SMCs co-expressed collagen and elastin, giving rise to engineered
arterial constructs with physiologic compliance. PGS constructs
contained more than a third of the insoluble elastin content of
porcine common carotid arteries. Arteries, PGS constructs, and PGS
scaffolds demonstrated elastic deformation and recovery, while
segments of PLGA constructs and PLGA scaffolds demonstrated
plastic deformation under identical testing conditions. Short-term
culture with SMCs significantly increased scaffold stiffness
regardless of material and shifted the stiffness of PGS scaffolds
closer to that of porcine carotid arteries. Compared to PLGA, PGS
promoted elastin deposition by SMCs but attenuated collagen
deposition. Soluble elastin concentration in culture medium was
equivalent for PLGA and PGS constructs, as were luminal conflu-
ence. The creation of a clinically successful tissue-engineered artery
requires not only compliance matching but also sufficient burst
pressure and the incorporation of a robust and functional endo-
thelium. We have previously demonstrated co-culture of endo-
thelial progenitor cells and SMCs in PGS constructs [25]. The results
of this study combined with former studies therefore provide
a possible avenue for engineering non-thrombogenic vascular
grafts with physiologic compliance.Acknowledgments
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